Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Capital Expenditures (2016 - 2025)

Prestige Consumer Healthcare has reported Capital Expenditures over the past 16 years, most recently at $3.0 million for Q4 2025.

  • Quarterly results put Capital Expenditures at $3.0 million for Q4 2025, up 93.36% from a year ago — trailing twelve months through Dec 2025 was $9.4 million (up 19.76% YoY), and the annual figure for FY2025 was $8.2 million, down 13.88%.
  • Capital Expenditures for Q4 2025 was $3.0 million at Prestige Consumer Healthcare, up from $2.1 million in the prior quarter.
  • Over the last five years, Capital Expenditures for PBH hit a ceiling of $4.9 million in Q1 2021 and a floor of $838000.0 in Q2 2025.
  • Median Capital Expenditures over the past 5 years was $2.2 million (2021), compared with a mean of $2.3 million.
  • Biggest five-year swings in Capital Expenditures: plummeted 69.64% in 2021 and later soared 93.36% in 2025.
  • Prestige Consumer Healthcare's Capital Expenditures stood at $2.2 million in 2021, then fell by 19.11% to $1.8 million in 2022, then increased by 10.7% to $2.0 million in 2023, then dropped by 21.54% to $1.6 million in 2024, then soared by 93.36% to $3.0 million in 2025.
  • The last three reported values for Capital Expenditures were $3.0 million (Q4 2025), $2.1 million (Q3 2025), and $838000.0 (Q2 2025) per Business Quant data.